Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

7.79
Delayed Data
As of Aug 28
 +0.01 / +0.13%
Today’s Change
6.56
Today|||52-Week Range
11.71
-11.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues34.3M41.4M33.6M37.9M
 
 
 
 
 
Cost of Goods Sold6.0M7.4M4.6M5.7M
 
 
 
 
 
Depreciation And Amortization221.0K200.0K231.0K288.0K
 
 
 
 
 
 
Operating ExpensesGross Income28.1M33.8M28.7M32.0M
 
 
 
 
 
General Expenses20.0M30.2M19.3M26.0M
 
 
 
 
 
Research And Development432.0K11.4M857.0K6.3M
 
 
 
 
 
Total Operating Expenses26.2M37.8M24.1M32.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.1M3.6M9.5M5.9M
 
 
 
 
 
Extraordinary Charge0.00--0.00-10.8M
 
 
Other Expenses108.0K261.0K-63.0K39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income8.2M3.9M9.5M-4.6M
 
 
 
 
 
Income Taxes-331.0K-406.0K-570.0K-546.0K
 
 
 
 
 
Net Income7.9M3.5M9.0M-4.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.0M50.5M50.0M49.9M
 
 
 
 
 
Shares To Calculate EPS Diluted52.4M52.8M52.3M49.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.15$0.07$0.17-$0.08
 
 
 
 
 
EPS Diluted$0.15$0.07$0.17-$0.08